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Simple Summary: Bacterial strains that are consumed by humans or by animals to promote health
are called probiotics. In poultry, Bacillus strains are widely used as feed additives for this purpose.
Although different modes of action have been proposed, studies showing effects on what metabolites
the bacteria produce in a test tube, and whether these can also be found in the intestine of animals
that were given these strains as feed additives, are lacking. In the current study, we show that
administration of a Bacillus strain to broiler chickens changes the microbial composition in the gut
by reducing opportunistic pathogenic bacterial families and promoting beneficial bacterial families.
We show that two molecules, hypoxanthine and nicotinic acid, are produced by the Bacillus strain
and are elevated in the intestinal tract of these animals. We hypothesize that nicotinic acid can be
used by beneficial microbes and is essential for their intestinal colonization, and that both molecules
can have a positive effect on the intestinal wall. These data can be used to evaluate and develop
novel feed additives to promote health of chickens, and reduce the need for antibiotic usage.
Abstract: The probiotic Bacillus subtilis strain 29784 (Bs29784) has been shown to improve perfor-
mance in broilers. In this study, we used a metabolomic and 16S rRNA gene sequencing approach to
evaluate effects of Bs29874 in the broiler intestine. Nicotinic acid and hypoxanthine were key metabo-
lites that were produced by the strain in vitro and were also found in vivo to be increased in small
intestinal content of broilers fed Bs29784 as dietary additive. Both metabolites have well-described
anti-inflammatory effects in the intestine. Furthermore, Bs29784 supplementation to the feed signifi-
cantly altered the ileal microbiome of 13-day-old broilers, thereby increasing the abundance of genus
Bacillus, while decreasing genera and OTUs belonging to the Lactobacillaceae and Enterobacteriacae
families. Moreover, Bs29784 did not change the cecal microbial community structure, but specifically
enriched members of the family Clostridiales VadinBB60, as well as the butyrate-producing families
Ruminococcaceae and Lachnospiraceae. The abundance of various OTUs and genera belonging to these
families was significantly associated with nicotinic acid levels in the cecum, suggesting a possible
cross-feeding between B. subtilis strain 29784 and these beneficial microbes. Taken together, the data
indicate that Bs29784 exerts its described probiotic effects through a combined action of its metabolites
on both the host and its microbiome.
Keywords: probiotics; Bacillus subtilis; metabolites; intestinal health; nicotinic acid; hypoxanthine;
16S rRNA gene sequencing; broilers
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1. Introduction
Probiotics are used in both human and animal nutrition for their health benefits.
In animal diets, probiotics are included as feed additives to create a healthy and resilient
intestinal microbial environment [1–3]. Maintaining a beneficial intestinal microbial com-
position helps in improving the overall health of the animal and thereby positively affects
body weight gain (BWG) and feed conversion ratio (FCR) [4,5].
Many different microorganisms are used as probiotics in poultry production. Bacillus spp.
are the most commonly used probiotic microorganisms because of their ability to form
endospores [6]. This enables them to survive the feed manufacturing process and the
passage through the stomach. Moreover, spores allow easy administration, storage and
prolonged shelf-life [6]. One frequently used species, Bacillus subtilis, is considered to be
safe for consumption [7,8]. A variety of B. subtilis strains are available as feed additives for
animals with each having their own strain specificity. One example is B. subtilis strain 29784
(Bs29784), for which beneficial effects on growth performance are consistently reported in
broilers, turkeys and layer pullets [9–12]. In addition, the strain reduces IL-8 expression
and improves intestinal barrier integrity by upregulating tight junction protein expression,
as was shown in a cell culture model [13]. Although effects of the administration of Bacillus
strains on intestinal health parameters have been observed, insights in the exact modes
of action of these probiotic strains are often limited. Different modes of action have been
suggested in literature, including vitamin and nutrient production, enzyme production,
antagonistic effects on pathogens, pH reduction due to short-chain fatty acids (SCFA) and
lactate production, amongst others, but causal relationships between the produced metabo-
lites and the observed effects are generally not proven [14–16]. Studies investigating the
metabolites produced by probiotic strains have focused mainly on fermentation products
such as lactic acid and SCFA, while, to the best of our knowledge, none have carried out a
metabolome analysis and verified whether the metabolites produced in vitro could also
be detected in the intestinal tract. Therefore, the aim of the current study was to identify
metabolites that are produced by the probiotic B. subtilis strain Bs29784 in vitro, elucidate
whether these metabolites are also produced in the chicken intestinal tract after in-feed
supplementation of Bs29784, and how Bs29784 affects the intestinal microbiome.
2. Materials and Methods
2.1. Bacterial Strain and Growth Conditions
Bs29784 is a commercially available probiotic for broilers (Alterion® NE, Adisseo,
Commentry, France). The commercial product contains 1010 CFU/g spores of B. subtilis
strain 29784 and is mixed at 1 g/kg in the feed that is supplied to broilers. For in vitro
experiments, a pure culture of Bs29784 was obtained by inoculating the commercial probi-
otic in Luria–Bertani (LB) broth (Sigma-Aldrich, St. Louis, MO, USA). The bacteria were
grown overnight at 37 ◦C under aerobic conditions. Bacteria were plated on LB plates and
their identity was confirmed via matrix-assisted laser desorption/ionization time of flight
mass spectrometry (MALDI-TOF MS) [17] and Sanger sequencing of the 16S region [18].
Bacterial growth was determined in LB broth over a 24-hour time span (grown in triplicate).
Bacterial supernatant was obtained by centrifugation (5 min, 13,300 rpm) and filtered
using a Polyvinylidene difluoride (PVDF) membrane filter (0.22 µm × 13 mm diameter,
Kynar 500®, Arkema, Amsterdam, The Netherlands). Blank samples (medium without
bacteria) were incubated simultaneously with the bacterial samples and processed in the
same way to serve as controls. Samples were stored at −80 ◦C until metabolomic analysis.
2.2. Animal Trial
The study was undertaken following the guidelines of the ethics committee of the
Faculty of Veterinary Medicine, Ghent University, in accordance with the EU Directive
2010/63/EU. One-day-old Ross 308 broiler chicks were obtained from a local hatchery and
divided into 2 groups of 5 birds consisting of (1) a control group that received a standard
commercial diet and (2) a group that received a standard commercial diet supplemented
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with the commercial Bs29784 probiotic at a dose of 1010 CFU/kg feed (FARM 1&2 mash,
Versele-laga, Deinze, Belgium). Animals were housed on a solid floor covered with wood
shavings at a density of 5 birds/m2. Animals were subjected to a light schedule of 12 h
light and 12 h dark. All broilers were given water and feed ad libitum. At 13 days of age,
all birds were weighed, the birds were euthanized, and digestive content from the jejunum,
ileum and cecum was collected. These samples were frozen in liquid nitrogen directly after
sampling and stored at −20 ◦C until further processing. The material from the 3 sections
was used for metabolomic analysis and Bacillus quantification, while the ileal and cecal
content was used for 16S sequencing. At 13 days of age, no differences in bodyweight
could be observed, with an average bodyweight of 273.4 g ± 19.54 g (mean ± SD) for the
control group and 254.3 g ± 38.37 g for the Bs29784-supplemented group (p = 0.358).
2.3. Targeted Metabolomics
2.3.1. Reagents and Chemicals
Analytical standards [19] were obtained from Sigma-Aldrich (St. Louis, MO, USA),
ICN Biomedicals Inc. (Costa Mesa, CA, USA) or TLC Pharmchem (Vaughan, ON, Canada).
Solvents were obtained from Fisher Scientific UK and VWR International (Merck, Darm-
stadt, Germany). All analytical standards, including nicotinic acid (Sigma-Aldrich) and
hypoxanthine (Sigma-Aldrich), as well as the internal standard valine-d8 (ISTD) (Sigma-
Aldrich), were stored at −20 ◦C in a primary stock solution of 10 mg/mL in either ultrapure
water or methanol.
2.3.2. Instrumentation
A polar metabolomics approach was applied based on the method described by Van-
den Bussche et al. (2015) [20]. An Accela UHPLC system of Thermo Fisher Scientific (San
José, CA, USA) was used, with an Acquity HSS T3 C18 column (1.8 µm, 150 mm × 2.1 mm,
Waters). As binary solvent system, ultrapure water with 0.1% formic acid (A) and acetoni-
trile acidified with 0.1% formic acid (B) were used at a constant flow rate of 0.4 mL/min.
A gradient profile of solvent A was applied (0−1.5 min at 98% (v/v), 1.5−7.0 min from
98% to 75% (v/v), 7.0−8.0 min from 75% to 40% (v/v), 8.0−12.0 min from 40% to 5% (v/v),
12.0−14.0 min at 5% (v/v), 14.0−14.1 min from 5% to 98% (v/v)), followed by 4.0 min of
re-equilibration. Solvents used for UHPLC-MS/MS analysis were purchased from Fisher
Scientific UK. HRMS analysis was performed on an Exactive stand-alone benchtop Orbi-
trap mass spectrometer (Thermo Fisher Scientific), equipped with a heated electrospray
ionization source (HESI), operating in polarity switching mode.
2.3.3. Optimization of the UHPLC-HRMS Method
Optimization of the method of Vanden Bussche et al. (2015) [20] was performed in
a preliminary run to exclude matrix effects and to determine the optimal concentration
of the bacterial supernatant samples. For this purpose, quality control (QC) samples
made from pooled biological samples were considered as representative bulk control
samples [21]. QC samples were extracted and serially diluted with ultrapure water (1;
1:2, 1:5, 1:10, 1:20, 1:50, 1:100, 1:200 and 1:500), after which the linearity was studied
based on the coefficient of determination (R2). The targeted analysis was based on an
in-house metabolite mixture containing 291 known metabolites which are important in the
gut. This mixture of metabolites was run to standardize and determine respective peaks
found in the samples [22]. The absolute peak areas of the ISTD and of one representative
metabolite from each category (multicarbon acids, monosaccharide, amino acid, imidazole,
ketones, etc.) in the list of known metabolites was determined. The following 11 metabolites
were analyzed: inositol, phenylacetic acid, succinate, histidyl leucine, glucose, 2-octanon,
L-methionine, L-arginine, spermidine, hypoxanthine and uracil. The validated metabolites
were required to have an R2 > 0.990. After validation, it was decided that a 1/10 dilution
was optimal for the supernatant samples.
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2.3.4. Metabolomic Analysis
Metabolites produced by Bs29784 in vitro were analyzed together with blank samples.
In vivo metabolite production was determined using intestinal digesta from chickens
receiving either non-supplemented feed or feed supplemented with Bs29784. Therefore,
intestinal content of the jejunum, ileum or cecum was freeze-dried for 24 h. To 100 mg
of freeze-dried material, 2 mL of ice-cold methanol (80:20) was added, vortexed and
centrifuged (9000 rpm, 10 min), after which the supernatant was filtered using a PVDF
filter (0.45 µm × 25 mm diameter) and used at a 1:3 dilution. Xcalibur 3.0 software (Thermo
Fisher Scientific, San José, CA, USA) was employed for targeted data processing, whereby
compounds were identified based on their m/z-value, C-isotope profile, and retention time
relative to that of the internal standard.
2.4. DNA Extraction from Intestinal Content
DNA was extracted from the jejunal, ileal and cecal content, using the hexadecyltrimethy-
lammonium bromide (CTAB) method described by Griffiths et al. [23] with modifications
described by Aguirre et al. [24]. The resulting DNA was resuspended in 50 µL of a 10 mM
Tris-HCl buffer (pH 8.0) and the quality and concentration of the DNA was examined spec-
trophotometrically (NanoDrop, Thermo Fisher Scientific, Merelbeke, Belgium).
2.5. Quantification of Bacillus spp. and Total Bacteria
The percentage bacteria belonging to the genus Bacillus (Bacillus spp.) relative to
the total number of bacteria found in the content from different intestinal segments was
determined using quantitative PCR (qPCR). Primers targeting Bacillus spp. (YB-P1 and
YB-P2) were used as described by Han et al. (2012) [25]. To determine the number of
total bacteria, primers Uni 331F and Uni 797R were used as described by Hopkins et al.
(2005) [26]. The qPCR was performed using the SensiFAST™ SYBR® No-ROX Kit (Bioline,
London, UK) with a 0.5 µM primer concentration. The PCR amplification consists of DNA
pre-denaturation at 95 ◦C for 2 min followed by 30 cycles of denaturation (95 ◦C for 15 s),
annealing (60 ◦C for 30 s) and extension (72 ◦C for 50 s).
2.6. 16S rRNA Gene Amplicon Sequencing
The V3–V4 hypervariable region of the 16s rRNA gene was amplified by using the
gene-specific primers S-D-Bact-0341-b-S-17 and S-D-Bact-0785-a-A-21 [27]. The PCR am-
plifications were performed as described by Aguirre et al. (2019) [24]. CleanNGS beads
(CleanNA, Gouda, The Netherlands) were used to purify PCR products. The DNA con-
centration of the final barcoded libraries was measured with a Quantus fluorimeter and
Quantifluor dsDNA system (Promega, Madison, WI, USA). The libraries were combined
to an equimolar 5 nM pool and sequenced with 30% PhiX spike-in using the Illumina
MiSeq v3 technology (2 × 300 bp, paired-end) at the Oklahoma Medical Research center
(Oklahoma City, OK, USA).
Demultiplexing of the amplicon dataset and deletion of the barcodes was done by the
sequencing provider. Quality of the raw sequence data was evaluated using the FastQC
quality control tool (Babraham Bioinformatics, Cambridge, UK), followed by an initial
quality filtering with Trimmomatic v0.38 [28]. Reads with an average quality per base
below 15 were cut using a four-base sliding window and reads with a minimum length
below 200 bp were discarded. The paired-end sequences were assembled and primers
were removed using PANDAseq [29], with a quality threshold of 0.9 and length cut-off
values for the merged sequences between 390 and 430 bp. Chimeric sequences were
removed using UCHIME [30]. Open-reference operational taxonomic unit (OTU) picking
was performed at 97% sequence similarity using USEARCH (v6.1) and converted to an
OTU table [31]. OTU taxonomy was assigned against the Silva database (v132, clustered at
97% identity) [32] using the PyNast algorithm with QIIME (v1.9.1) default parameters [33].
OTUs with a total abundance below 0.01% of the total sequences were discarded [34].
Potential contaminant chloroplastic and mitochondrial OTUs were removed from the
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dataset, resulting in an average of approximately 76,080 reads per sample, with a minimum
of 25,725. Alpha rarefaction curves were generated using the QIIME “alpha_rarefaction.py”
script and a subsampling depth of 25,000 reads was selected.
2.7. Metabolic Function Prediction of the Microbial Communities
Functional genes (KEGG orthologues, KOs) were inferred from the 16S amplicon se-
quencing data using Phylogenetic Investigation of Communities by Reconstruction of Unob-
served States (PICRUSt), as previously described [24,35]. The resulting KEGG orthologues
were further summarized into functional modules based on the Gut-specific Metabolic
Modules (GMM) database using GoMixer (Raes Lab) [36,37]. The contribution of various
taxa to different GMMs was computed with the script “metagenome_contributions.py”.
2.8. Statistical Analyses
Statistical analyses of the metabolomic and qPCR data were performed using Graph-
Pad PRISM (v8.4.3). A Kolmogorov–Smirnov test was performed to evaluate the data for
normal distribution. In case of normal distribution, an independent samples t-test was
performed. When data were not normally distributed, a non-parametric Mann–Whitney
test was performed. Tests were considered statistically significant at a p-value ≤0.05.
Biologically relevant metabolite production by Bs29784 in vitro was identified as a fold
change > 2 and p < 0.05.
Statistical analyses of the 16S data were performed using R (v3.6.0). Alpha diversity
was measured based on the observed OTUs (or observed KOs for the functional data),
Chao1 and Shannon diversity index using the phyloseq pipeline [38]. Differences in alpha
diversity were assessed using a Wilcoxon’s rank sum test. Beta diversity was calculated
using Bray–Curtis distance. Differences in beta diversity were examined by permutational
analysis of variance (Permanova) using the adonis function from the vegan package [39].
Differences in relative abundance at the phylum and family level were assessed using
the two-sided Welch t-test from the mt wrapper in phyloseq, with the p-value adjusted for
multiple hypothesis testing using the Benjamini–Hochberg method. The DESeq2 algorithm
was applied to identify differentially abundant genera or functional modules between the
control and Bs29784 group [40]. Significant differences were obtained using a Wald test
followed by a Benjamini–Hochberg multiple hypothesis correction. For all tests, an adjusted
p-value (q-value) ≤0.05 was considered significant. Biologically relevant differences in
functional modules between the birds fed a control diet or Bs29784-supplemented diet
were selected using a Log2 fold change (Log2FC) > 2 and q-value < 0.1.
The association of microbial abundances (at family, genus or OTU level), with hypox-
anthine and nicotinic acid levels measured in the intestinal content, were analyzed using
the multivariate analysis by linear models (MaAsLin2) R package. MaAsLin2 analysis
was performed separately on the ileal and cecal samples, while controlling for treatment
covariates [41].
3. Results
3.1. Identification of Metabolites Produced by Bs29784 In Vitro
Metabolites produced by Bs29784 after 24 h growth in LB medium were compared
to the blank medium. Overall, 123 of the 291 targeted metabolites could be detected in
either the blank LB medium and/or the supernatants of Bs29784 grown in LB (Table S1).
The majority of the detected metabolites (96/123, 78%) were not significantly altered after
growth of Bs29784 in the LB medium. In total, 21 metabolites (17% of the detected metabo-
lites) were significantly reduced due to growth of Bs29784 and 16 metabolites (13% of the
detected metabolites) were produced by Bs29784 in vitro (Table S1). Biologically relevant
metabolites were identified based on a fold change >2 and p < 0.05 (Table 1). The most
discriminatory metabolites, nicotinic acid and hypoxanthine (p < 0.0001), were selected for
evaluation in the in vivo samples.
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Table 1. Metabolites that are significantly increased (fold change > 2 and p < 0.05) after 24 h growth
of B. subtilis strain 29784 in LB medium.
Metabolite
Area Ratio (Mean ± SD)
Fold Change p-Value
Blank Bs29784
Hypoxanthine 0.173 ± 0.002 1.844 ± 0.086 106.40 <0.0001
Nicotinic acid 0.218 ± 0.030 1.853 ± 0.104 8.51 <0.0001
Ethanolamine 0.007 ± 0.003 0.061 ± 0.016 8.67 0.005
Uracil 0.241 ± 0.004 1.652 ± 0.392 6.85 0.003
Pantothenate 0.001 ± 0.001 0.022 ± 0.002 2.03 0.002
3-Hydroxypyridine 0.006 ± 0.003 0.014 ± 0.001 2.16 0.015
2.5-dimethylpyrazine 0.005 ± 0.000 0.012 ± 0.003 2.47 0.017
Thymine 0.014 ± 0.007 0.034 ± 0.004 2.51 0.011
3.2. Effect of Supplementation of Bs29784 in Broiler Feed on the Bacillus Load, Levels of
Hypoxanthine and Nicotinic Acid in the Intestinal Tract
The total number of bacteria, as well as the number of Bacillus spp. in the jejunum,
ileum and cecum were determined using qPCR. Supplementation of the diet with the
probiotic B. subtilis strain Bs29784 did not introduce alterations in the total bacterial load
(data not shown), but significantly increased the number of Bacillus spp. in the ileum
(p = 0.005), jejunum (p = 0.008), and cecum (p = 0.014) (Figure 1A–C).
To further assess whether this increase in Bacillus spp. was reflected in an increase
in Bs29784 metabolites, the levels of hypoxanthine and nicotinic acid were determined.
Overall, broilers fed a Bs29784-containing diet showed higher levels of hypoxanthine and
nicotinic acid in the intestinal content. The increase in hypoxanthine was most pronounced
in the ileum (p = 0.0003), but did not reach significance in the jejunum (p = 0.095) or cecum
(p = 0.171) (Figure 1D–F). In-feed supplementation of Bs29784 tended to increase the level of
nicotinic acid in the ileum (p = 0.051), as compared to birds fed the control diet, but had no
effect on nicotinic acid levels in the jejunum (p = 0.223) or cecum (p = 0.306) (Figure 1G–I).
3.3. Effect of Bs29784 Supplementation in Broiler Feed on the Ileal and Cecal Microbial Diversity
The microbial complexity in the ileum and cecum was estimated by calculating the
number of observed OTUs, the estimated OTU richness (Chao1) or the estimated commu-
nity diversity (Shannon index) in each sample. In-feed supplementation of Bs29784 had
no effect on the ileal microbial richness (observed OTUs or Chao1) (Table 2). However,
addition of Bs2978 to the diet significantly reduced the ileal community diversity (Shannon
index, p = 0.032). This is in contrast to the situation in the cecum, which had a tendency for
higher microbial richness in birds fed the Bs29784-supplemented diet, as compared to the
control diet (observed OTUs: p = 0.056, Chao1: p = 0.15), but no effect of Bs29784 on the
microbial community diversity was observed (Table 2).
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Table 2. Taxonomic and functional alpha diversity of ileal and cecal microbial communities from




nOTUs 98.8 ± 29.95 90 ± 16.02 0.69
Chao1 125.31 ± 49.39 107.59 ± 24.07 0.69
Shannon 1.72 ± 0.40 1.06 ± 0.43 0.032 *
Functional alpha diversity
nKOs 4487 ± 257.13 4522.6 ± 145.87 1
Chao1 4656.89 ± 375.39 4743.67 ± 298.32 1
Shannon 7.40 ± 0.23 7.16 ± 0.18 0.15
CECUM
Taxonomic alpha diversity
nOTUs 142.8 ± 5.45 181.2 ± 25.08 0.056
Chao1 157.74 ± 7.13 196.50 ± 30.77 0.15
Shannon 2.91 ± 0.41 3.26 ± 0.58 0.42
Functional alpha diversity
nKOs 4228.4 ± 111.10 4205.0 ± 76.41 1
Chao1 4554.97 ± 210.53 4414.80 ± 191.05 0.42
Shannon 7.71 ± 0.13 7.39 ± 0.14 0.016 *
* Significant differences between the control and Bs29784 group (p < 0.05).
Bray–Curtis dissimilarity was used to investigate beta diversity between either the
ileal or cecal microbiota from birds fed the control diet or the diet supplemented with
B. subtilis strain 29874. Supplementation of Bs29784 to the broiler diet showed a significant
clustering in the ileum, with 33.7% of the variation between the samples being explained
by the Bs29784 supplementation to the feed (p = 0.028) (Figure 2A). However, no effect on
the cecal microbial community composition was observed (diet explaining 17.4% of the
variation, p = 0.15) (Figure 2B).
3.4. Influence of Bs29784 on the Taxonomic Composition of the Ileal and Cecal Microbiome
The most abundant phyla in the ileum were Firmicutes (84.94% in control, 96.83% in
Bs29784) and Proteobacteria (12.81% in control, 2.24% in Bs29784), with a minor portion
belonging to the Verrucomicrobia (1.97% in control, 0.80% in Bs29784) and Actinobacteria
(0.28% in control, 0.13% in Bs29784). Also in the cecum, the Firmicutes was the most
prevalent phylum in both groups (48.16% in control, 68.37% in Bs29784), followed by
the Proteobacteria (26.27% in control, 10.54% in Bs29784) and Verrucomicrobia (24.29% in
control, 19.68% in Bs29784). The phylum Actinobacteria accounted for 1.28% and 1.41% of
the cecal microbiome in birds fed the control or Bs29784-supplemented diet, respectively.
Addition of Bs29784 to the broiler diet had no significant influence on either the ileal or
cecal microbiome at phylum level.
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Figure 2. PCoA plot of the taxonomic and functional microbial diversity from birds fed a control or
Bs29784-supplemented diet. Principal coordinate analysis (PCoA) plots of bacterial taxonomic (OTU-
level) (A,B) or functional (KO-level) (C,D) diversity calculated using the Bray–Curtis dissimilarity
metric. Each dot represents an individual chicken microbiome. Significant separation of the microbial
communities was observed in the ileum (p = 0.028) (A), but not the cecum (p = 0.153) (B). In both
the ileum and cecum, significant grouping of the samples was observed based on the functional KO
diversity (p = 0.024 and p = 0.029) (C,D).
In the ileum, the families Bacillaceae (<0.001% in control, 0.12% in Bs29784, padj = 0.06)
and Enterococcaceae (45.25% in control, 82.47% in Bs29784, padj = 0.17) tended to be more
abundant after probiotic sup lementation, whereas both the family Leuconostoca eae (0.25%
in control versus 0.0016% in Bs29784, padj = 0.06) and family Lactobacillaceae (24.45% in
control and 2.51% in Bs29784, padj = 0.17) tended to be less abundant in the ileum of birds
fed the Bs29784-supplemented diet. No significant effect of Bs29784 supplementation on
the families in the cecum could be observed.
Differentially abundant genera and OTUs in the ileal or cecal microbiome from birds
fed a Bs29784-supplemented diet as compared to the control diet were identified using
DESeq2 (Table 3; Tables S2 and S3). Nine genera were differentially abundant between
the ileal microbiota from birds fed eithe the control diet or the Bs29784 diet. Only the
genu Bacillus was significantly increased in the ileal microbiota f birds fed the Bs29784-
containing diet, a difference that could be fully attributed to a single OTU identified as
Bacillus subtilis (OTU4423422, Figure 3, Table S2). The other significantly altered genera and
OTUs in the ileal microbiome were all less abundant in Bs29784-fed birds, with multiple
genera belonging to the Enterobacteriaceae family, including multiple OTUs belonging to
genera Escherichia-Shigella and Enterobacter (Figure 3). Furthermore, addition of Bs29784
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to the broiler feed resulted in a reduction of the genus Pediococcus and Weissella, as well
as multiple OTUs belonging to the genus Lactobacillus in the ileal microbiome (Table 3,
Figure 3). In the cecum, Bs29784 supplementation of the broiler feed significantly reduced
the relative abundance of multiple genera belonging to the families Veillonellacaea and
Enterobacteriaceae, with main OTUs belonging to the genus Klebsiella (Figure 4, Table S3).
Additionally, an increase in members of the butyrate-producing families Ruminococcaceae
and Lachnospiraceae was observed in the cecum of Bs29784-fed birds. Moreover, the genus
Enterococcus, Clostridioides and a genus belonging to the Clostridiales vadinBB60 group were
significantly increased in the cecum by Bs29784 supplementation of the feed (Table 3).
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Table 3. Differentially abundant genera in the ileal or cecal microbiota.
Phylum Class Family Genus
Mean Abundance (%)
Log2 Fold Change Adjustedp-ValueControl Bs29784
ILEUM
Actinobacteria Actinobacteria Beutenbergiaceae Ambiguous taxa Beutenbergiaceae 0.046 0.000 −23.36 <0.001
Firmicutes Bacilli Bacillaceae Bacillus 0.000 0.121 7.54 <0.001
Firmicutes Bacilli Lactobacillaceae Pediococcus 0.250 0.035 −4.32 0.019
Firmicutes Bacilli Leuconostocaceae Weissella 0.253 0.002 −7.20 <0.001
Firmicutes Clostridia Peptostreptococcaceae Ambiguous taxa Peptostreptococcaceae 0.054 0.000 −22.66 <0.001
Firmicutes Negativicutes Veillonellaceae Family Veillonellaceae 0.062 0.000 −22.91 <0.001
Proteobacteria Gammaproteobacteria Enterobacteriaceae Ambiguous taxa Enterobacteriaceae 0.473 0.051 −3.71 0.007
Proteobacteria Gammaproteobacteria Enterobacteriaceae Enterobacter 0.045 0.002 −6.32 0.001
Proteobacteria Gammaproteobacteria Enterobacteriaceae Klebsiella 0.058 0.002 −6.09 0.007
CECUM
Firmicutes Bacilli Enterococcaceae Enterococcus 1.746 4.865 2.30 0.016
Firmicutes Clostridia Clostridiales vadinBB60 group uncultured bacterium_Clostridiales vadinBB60 group 0.000 0.956 12.51 <0.001
Firmicutes Clostridia Lachnospiraceae [Eubacterium] hallii group 0.000 0.074 22.48 <0.001
Firmicutes Clostridia Lachnospiraceae GCA-900066575 0.000 0.062 22.47 <0.001
Firmicutes Clostridia Lachnospiraceae Lachnospiraceae FCS020 group 0.004 0.219 7.32 <0.001
Firmicutes Clostridia Lachnospiraceae Lachnospiraceae NK4A136 group 0.000 0.556 25.64 <0.001
Firmicutes Clostridia Peptostreptococcaceae Clostridioides 0.000 0.066 23.25 <0.001
Firmicutes Clostridia Ruminococcaceae Negativibacillus 0.000 0.693 11.10 <0.001
Firmicutes Clostridia Ruminococcaceae Ruminiclostridium 9 0.239 1.359 2.93 0.0461
Firmicutes Clostridia Ruminococcaceae Ruminococcaceae UCG-013 0.000 0.008 27.52 <0.001
Firmicutes Negativicutes Veillonellaceae Family_Veillonellaceae 1.272 0.000 −27.55 <0.001
Firmicutes Negativicutes Veillonellaceae Sporomusa 3.657 0.000 −28.07 <0.001
Proteobacteria Gammaproteobacteria Enterobacteriaceae Ambiguous_taxa_Enterobacteriaceae 5.518 0.758 −2.48 <0.001
Proteobacteria Gammaproteobacteria Enterobacteriaceae Enterobacter 0.718 0.059 −3.03 0.004
Proteobacteria Gammaproteobacteria Enterobacteriaceae Klebsiella 3.221 0.745 −2.33 0.006
Significant differences in genus level abundance in the ileal or cecal microbiota from birds fed the Bs29784-supplemented diet as compared to the control diet. The taxonomic classification and the log2 fold change (log2FC)
(Bs29784/control) of the DESeq2-normalized abundance of each genus are shown. Positive values indicate an increase in abundance of the respective genus in the Bs29784 group, while negative values indicate a decrease.
Animals 2021, 11, 1335 13 of 21
3.5. Hypoxanthine and Nicotinic Acid Levels Are Associated with Specific Microbial Taxa in
the Cecum
Associations between the hypoxanthine and nicotinic acid levels and microbial abun-
dances in either the ileum or cecum were analyzed using multivariate association with
linear models (MaAsLin2), while controlling for the type of diet (control diet or Bs29784-
supplemented diet). In the ileum, no associations between metabolite levels and the
abundance of specific microbial taxa were observed. In the cecum, the genus DTU089 (fam-
ily Ruminoccocaceae) was significantly associated with the hypoxanthine levels (p = 0.001,
q = 0.022) and inversely correlated with the nicotinic acid levels (p = 0.006, q = 0.099).
These associations were also significant at the OTU level (Figure 5). Additionally, a similar
association between metabolite levels and a single OTU belonging to the family Lach-
nospiraceae was observed (Figure 5). No other associations with hypoxanthine levels
in the cecum could be observed. In contrast with the limited number of microbiome–
hypoxanthine associations, the effect of nicotinic acid on the cecal microbiome was more
pronounced. Nicotinic acid levels were positively associated with 17 OTUs, mainly ones
belonging to the families Lachnospiraceae and Ruminococcaceae (Figure 5). Five out of sev-
enteen OTUs (29.4%) that were associated with the cecal nicotinic acid levels belong to
Faecalibacteria, and were mainly identified as F. prausnitzii (4/5 Faecalibacterium OTUs).
These microbiome–nicotinic acid associations were also significant at the genus level,
and even the family level, for both the family Ruminococcaceae (p = 0.012, q = 0.222) and
family Clostridiales vadinBB60 group (p = 0.001, q = 0.024).
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3.6. In-Feed Bs29784 Supplementation Decreases the Abundance of Specific Microbial
Metabolic Modules
To determine whether the Bs29784-induced alterations of the microbiota might have
an effect on the microbial functions, the functional genes (KEGG orthologs) present in the
ileal and cecal microbiome were in silico predicted and grouped into gut-specific metabolic
modules (GMMs). In total, 5135 and 4674 KOs were identified in, respectively, the ileal
and cecal microbiome. In-feed supplementation of Bs29784 had no effect on both the
ileal and cecal functional richness (number of observed KOs or Chao1 richness estimator),
but reduced the diversity of the functional genes (Shannon diversity, ileum: p = 0.15, cecum:
p = 0.016) (Table 2). Beta-diversity analysis based on Bray–Curtis showed significant
clustering in both the ileum and cecum with 28.0% and 33.8% of the variation between
the samples being explained by the Bs29784 supplementation to the feed (ileum: p = 0.024,
cecum: p = 0.029) (Figure 2C,D).
Based on the identified functional genes, 127 and 126 gut metabolic functional modules
(GMM) could be constructed in, respectively, the ileum and cecum. None of the GMMs
were significantly more abundant in either the ileum or cecum from birds receiving the
Bs29784-supplemented feed. However, 13 GMMs were significantly less abundant in
the ileum, whereas 7 GMMs were reduced in the cecum of Bs29784-fed birds (Tables S4
and S5). The affected GMMs can be classified in seven functional categories: amines and
polyamines degradation (MF004), amino acid degradation (MF0015, MF0024, MF0036,
MF0037 and MF0041), carbohydrate degradation (MF0045, MF0052), gas metabolism
(MF0095), inorganic nutrient metabolism (MF0104), lipid degradation (MF0106, MF0111)
and organic acid metabolism (MF0118, MF0120, MF0125, MF0128).
To further address the metagenomic potential of the ileal and cecal microbiota, the rel-
ative abundance of the GMMs of interest (Figure 6) as well as the microbial taxa puta-
tively contributing to the selected pathways were identified (Figure 7, Tables S6 and S7).
In the ileum, the majority of the changes in predicted metabolic modules could, at least
partly, be attributed to members of the family Enterobacteriaceae (Figure 7A). Additionally,
the genus Akkermansia within the family Verrucomicrobiaceae contributed for a large part
to the observed reduction of a selection of GMMs (MF0106, MF0111, MF0118, MF0125),
which are mainly involved in lipid degradation and organic acid metabolism (Figure 7A).
In addition to the family Enterobacteriaceae, the Lactobacillaceae were main contributors to
the arginine degradation (MF0036) and trehalose degradation (MF0045) modules, whereas
the Clostridiaceae were in large part responsible for the histidine degradation (MF0041)
module. Other bacterial families had only minor taxonomic contributions to the differ-
ences in metabolic modules encoded by the ileal microbiome from broilers fed a control or
Bs29784-supplemented diet (Figure 7A, Table S6).
In the cecum, members of the family Enterobacteriaceae were contributing greatly to the
observed differences in metabolic modules (Figure 7B). This effect of the Enterobacteriaceae
is partially counteracted by a taxonomic increase of the families Ruminococcaceae and Lach-
nospiraceae, which specifically contribute to the modules encoding for arginine degradation
(MF0036), anaerobic fatty acid beta-oxidation (MF0106) and lactate consumption (MF0120)
(Figure 7B). Additionally, the genus Akkermansia (family Verrucomicrobiaceae) had a large
share in the abundance of modules MF0106 and MF0037, but it did not influence the overall
module abundance (Figure 7B).
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gray; Bs29784: light gray). The log2 of the module counts per family are shown on a blue–red scale.
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MF0004: putrescine degradation, MF0015: glutamate degradation, MF0024: methionine degradation,
MF0036: arginine degradation (ornithine decarboxylase pathway), MF0037: arginine degradation
(AST/succinyltransferase pathway), MF0041: histidine degr dation, MF0045: trehal se degrada-
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4. Discussion
The Bacillus subtilis strain 29784 was previously shown to improve growth performance
in broilers, turkeys and layer pullets [10–12], have a beneficial effect on the gut mucosal
morphology in broilers [9] and increas the abu dances f butyrate-producing bacteria
in the ceca of both broilers and layer pullets [9,42]. Moreover, Bs29784 was shown to
possess anti-inflammatory properties and enhance epithelial barrier integrity in vitro [13].
However, how Bs29784 modulates the microbiome and interacts with the host was largely
unknown. In this study, we identified nicotinic acid and hypoxanthine as important
metabolites that might contribute to the above-described host- and microbiome-modulating
effects of Bs29784. Indeed, nicotinic acid and hypoxanthine were produced by Bs29784
in vitro and were also increased in the ileum of broilers fed a Bs29784-supplemented diet.
Bacillus subtilis spores have been found to germinate in the small intestine of mice [43]
and chickens [44]. The observed increase of hypoxanthine and nicotinic acid in the small
intestine of broilers fed a Bs29784-supplemented diet indicates that the Bs29784 spores
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were germinating in the intestine and suggests that Bacillus-produced metabolites are able
to actively contribute to the metabolite pool produced by the gastrointestinal microbiome.
In-feed supplementation of Bs29784 induces a shift in the cecal microbiome towards
butyrate-producing bacteria, which can at least partly be explained by the metabolites
produced by Bs29784. Although no changes were observed in the overall community
structure, Bs29784 specifically decreased the abundance of multiple genera belonging to
the families Veillonellaceae and Enterobacteriaceae, while increasing members of the families
Clostridiales VadinBB60, Ruminococcaceae and Lachnospiraceae. This is in accordance with
previous studies in both broilers and layers, where B. subtilis strain 29784 increased the cecal
abundance of the butyrate-producing families Ruminococcaceae and Lachnospiraceae [9,42].
In this study, we showed that the abundance of various OTUs and genera belonging to the
Clostridiales VadinBB60, Ruminococcaceae and Lachnospiraceae was significantly associated
with nicotinic acid levels in the cecum. A similar association between nicotinic acid
levels in the gut and the genus Faecalibacterium was previously observed in samples from
inflammatory bowel disease (IBD) patients [45]. In both IBD patients and in our study,
this association could mainly be attributed to Faecalibacterium prausnitzii. As F. prausnitzii is
auxotroph for nicotinic acid, it has to acquire this nutrient form the environment [46,47],
suggesting possible cross-feeding between B. subtilis strain 29784 and F. prausnitzii in
the gut. Moreover, various members of the Ruminococcaceae and Lachnospiraceae lack the
pathways for de novo synthesis of several other B-vitamins (mostly vitamin B1 (thiamin),
B5 (pantothenate), B6 (pyridoxine) and B7 (biotin)), while these pathways were encoded
in the genome of various B. subtilis strains [48]. Therefore, it might be that the observed
association between nicotinic acid and these bacteria is caused by the production of other
B vitamins by Bs29784. Indeed, we showed that Bs29784 is able to produce pantothenate
in vitro. However, this vitamin was not further investigated in this study. Whether or
not Bs29784 is able to produce other B-vitamins and steer the microbiome towards an
anti-inflammatory community through cross-feeding remains to be elucidated.
Bs29784 addition to the broiler diet changes the microbial community structure in the
ileum, thereby mainly reducing the abundance of various genera and OTUs belonging
to the Lactobacillaceae and Enterobacteriaceae, while increasing the abundance of B. subtilis.
This is in contrast to a previous study where in-feed supplementation of Bs29784 had no
effect on the ileal microbiome in broilers [9]. This difference might be attributed to the age
of the birds, where the aforementioned study used 42-day-old broilers, while our study
aimed at studying the more dynamic microbiome of 13-day-old birds. Moreover, supple-
mentation of B. subtilis strain 29784 in the feed of broilers reduced the abundance of several
functional modules, which were mainly involved in amino acid degradation or organic
acid metabolism. This effect on the microbial functional potential was less pronounced
in the cecal microbiome and was in large part due to a reduction in Enterobacteriaceae.
As no association was observed between hypoxanthine or nicotinic acid levels and the
microbiome in the ileum, it is unclear how Bs29784 exerts its microbiome-modulating effect
in the ileum. One possibility is that the observed microbiome effects are caused by the
production of anti-microbial peptides by Bs29784 or through an indirect effect of Bs29784 on
the host. Alternatively, it might be that the number of animals used in this study (n = 5 per
group) did not yield enough statistical power to discover possible associations between the
Bs29784-produced metabolites and the ileal microbiome.
In addition to the abovementioned effects on the microbiome, beneficial effects on in-
testinal health for both hypoxanthine and nicotinic acid were previously reported. Reduced
faecal levels of hypoxanthine or nicotinic acid have both been linked with IBD [45,49,50].
Furthermore, both metabolites are able to ameliorate experimental colitis [51,52]. Addition-
ally, nicotinic acid treatment promoted mucosal healing in patients with moderately active
ulcerative colitis [51].
Hypoxanthine is a breakdown product of nucleic acids and can be taken up and
incorporated by intestinal bacteria or the host via the nucleotide salvage pathway [53].
Additionally, hypoxanthine from the microbiota is salvaged for energy and nucleotide
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biosynthesis in intestinal epithelial cells, thereby supporting wound healing, mucus gener-
ation and intestinal barrier function [49,52,54]. Notably, hypoxanthine has also been shown
to act as a substrate for the antimicrobial function of the enzyme xanthine oxidoreductase
(XOR) which is located on the outer surface of epithelial cells [38,39]. XOR is responsible
for the conversion of hypoxanthine to xanthine and from xanthine to uric acid. During both
reactions, oxygen is reduced, generating hydrogen peroxide (H2O2) and reactive oxygen
species (ROS) [55,56]. XOR-generated H2O2 has been shown to act as an effective antimi-
crobial agent against commensal microorganisms and anaerobes, although pathogenic
bacteria could be more resistant [56]. Moreover, XOR-generated ROS have been hypoth-
esized to initiate neutrophil infiltration in response to pro-inflammatory mediators [57].
These neutrophils can then help to combat infections. In chickens, XOR is mainly expressed
in the intestine, liver and pancreas [58]. It is thus possible that hypoxanthine produced by
Bs29784 contributes to intestinal health through enhancing epithelial barrier function and
mucus production, while protecting the intestinal epithelial cells against microorganisms
through H2O2 production. This could be one of the reasons a reduction in several genera
of the Enterobacteriaceae, such as Enterobacter and Escherichia-Shigella, is seen in the ileum
of broilers fed Bs29784-supplemented feed.
Nicotinic acid, or niacin (pyridine-3-carboxylic acid), is a form of vitamin B3, an essen-
tial nutrient for animals, including broilers. In humans and rodents, nicotinic acid is known
to bind on the GPR109A receptor (aka HCA2 or HM74a in humans and NIACR1 in rodents),
which is also one of the receptors for butyrate [59–61]. GPR109A has been shown to act as
an anti-inflammatory mediator via the β-arrestin signaling pathway, protecting epithelial
cells against inflammation and oxidative stress [61]. It is unclear whether nicotinic acid
induces similar effects in birds, since an equivalent homologous receptor has not yet been
identified. Nevertheless, nicotinic acid shows comparable effects on the regulation of the
lipid transport apolipoproteins apoA and apoB in broilers as in humans which is medi-
ated by GPR109A in the latter [62]. Furthermore, nicotinic acid is an important precursor
for the coenzymes nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine
dinucleotide phosphate (NADP) that play an essential role in, among others, antioxidant
protection [63,64]. This suggests that nicotinic acid, produced among others by Bs29784,
may be taken up by the epithelial cells, protecting the cells from oxidative stress, while at
the same time H2O2 is generated outside the cell by the action of the cell-surface xanthine
oxidoreductase on hypoxanthine, also produced among others by Bs29784.
5. Conclusions
In conclusion, this study identified hypoxanthine and nicotinic acid as two important
metabolites produced by B. subtilis strain 29784. The probiotic was shown to be metaboli-
cally active, producing these two metabolites in the intestine of broilers. These metabolites
contribute, at least in part, to the interaction of Bs29784 with both the host and the micro-
biome, either through direct anti-inflammatory or anti-bacterial properties or by increasing
the abundance of beneficial butyrate-producing bacteria in the cecum, potentially through
cross-feeding.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ani11051335/s1, Table S1: Metabolites detected in either blank LB medium or after 24 h
growth of B. subtilis strain Bs29784 on LB medium, Table S2: Differentially abundant OTUs in the
ileal microbiome of birds fed either the control or Bs29784-supplemented diet, Table S3: Differentially
abundant OTUs in the cecal microbiome of birds fed either the control or Bs29784-supplemented diet,
Table S4: Differentially abundant gut metabolic modules (GMM) in the ileal microbiome of birds fed
either the control or Bs29784-supplemented diet, Table S5: Differentially abundant gut metabolic
modules (GMM) in the cecal microbiome of birds fed either the control or Bs29784-supplemented
diet, Table S6: Mean and SEM of the number of times a bacterial family contributes to a specific
module in the ileum, Table S7: Mean and SEM of the number of times a bacterial family contributes
to a specific module in the cecum.
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